Lingfei Kong

2.5k total citations
108 papers, 1.7k citations indexed

About

Lingfei Kong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Lingfei Kong has authored 108 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 31 papers in Pulmonary and Respiratory Medicine and 21 papers in Oncology. Recurrent topics in Lingfei Kong's work include Asthma and respiratory diseases (16 papers), Cancer-related molecular mechanisms research (10 papers) and Respiratory and Cough-Related Research (10 papers). Lingfei Kong is often cited by papers focused on Asthma and respiratory diseases (16 papers), Cancer-related molecular mechanisms research (10 papers) and Respiratory and Cough-Related Research (10 papers). Lingfei Kong collaborates with scholars based in China, United States and Switzerland. Lingfei Kong's co-authors include Xinzheng Zhang, Xinming Su, Duanfang Cao, Yuan Ren, Jian Kang, Menglu Li, Tingyi Sun, Xuan Zhao, Kefang Lai and Na Yu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Lingfei Kong

101 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingfei Kong China 23 564 484 350 205 199 108 1.7k
Lili Lu China 23 729 1.3× 303 0.6× 171 0.5× 131 0.6× 161 0.8× 60 1.6k
Rebecca E. Oberley‐Deegan United States 23 619 1.1× 420 0.9× 149 0.4× 153 0.7× 148 0.7× 72 1.8k
Shijie Wang China 20 507 0.9× 289 0.6× 105 0.3× 136 0.7× 247 1.2× 104 1.4k
Giusi Irma Forte Italy 24 631 1.1× 368 0.8× 174 0.5× 248 1.2× 317 1.6× 83 2.1k
Naoto Yamaguchi Japan 31 976 1.7× 329 0.7× 285 0.8× 145 0.7× 128 0.6× 105 2.5k
Wei‐Ting Chang Taiwan 23 579 1.0× 262 0.5× 96 0.3× 172 0.8× 101 0.5× 155 1.9k
Huan Liu China 26 691 1.2× 390 0.8× 157 0.4× 47 0.2× 272 1.4× 151 2.0k
Juanjuan Xu China 27 688 1.2× 340 0.7× 120 0.3× 107 0.5× 338 1.7× 80 2.1k
Joo‐Young Kim South Korea 28 647 1.1× 418 0.9× 280 0.8× 220 1.1× 239 1.2× 146 2.7k
Sung Chul Hwang South Korea 24 1.4k 2.5× 407 0.8× 293 0.8× 71 0.3× 204 1.0× 66 2.5k

Countries citing papers authored by Lingfei Kong

Since Specialization
Citations

This map shows the geographic impact of Lingfei Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfei Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfei Kong more than expected).

Fields of papers citing papers by Lingfei Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingfei Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfei Kong. The network helps show where Lingfei Kong may publish in the future.

Co-authorship network of co-authors of Lingfei Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Lingfei Kong. A scholar is included among the top collaborators of Lingfei Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingfei Kong. Lingfei Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Guo, Huihui, Yanxing Han, Zhen Shen, et al.. (2024). Alleviation of allergic asthma by rosmarinic acid via gut-lung axis. Phytomedicine. 126. 155470–155470. 9 indexed citations
3.
Tian, Yingjie, et al.. (2024). Artificial intelligence model predicts M2 macrophage levels and HCC prognosis with only globally labeled pathological images. Frontiers in Oncology. 14. 1474155–1474155. 1 indexed citations
4.
Zhang, Jianlin, Yuan Chang, Lingfei Kong, et al.. (2024). H-ferritin-nanocaged gadolinium nanoparticles for ultra-sensitive MR molecular imaging. Theranostics. 14(5). 1956–1965. 16 indexed citations
5.
Kong, Lingfei, et al.. (2023). The influence of Hyssopus cuspidatus Boriss extract on lipid mediators metabolism network in asthmatic mice. Frontiers in Pharmacology. 14. 1066643–1066643. 6 indexed citations
6.
Liu, Guanzheng, Zhiyue Zhang, Meiyun Wang, et al.. (2023). Genomic alterations of oligodendrogliomas at distant recurrence. Cancer Medicine. 12(16). 17171–17183. 8 indexed citations
7.
Li, Jing, Jing Yang, Lingfei Kong, et al.. (2020). Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians. Asian Pacific Journal of Allergy and Immunology. 40(3). 223–231. 8 indexed citations
8.
Su, Xinming, Yuan Ren, Menglu Li, Lingfei Kong, & Jian Kang. (2020). Association of glutathione S-transferase M1 and T1 genotypes with asthma. Medicine. 99(34). e21732–e21732. 5 indexed citations
9.
Shi, Yujie, Zhikun Ma, Qiong Cheng, et al.. (2020). FGFR1 overexpression renders breast cancer cells resistant to metformin through activation of IRS1/ERK signaling. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(1). 118877–118877. 15 indexed citations
10.
Li, Dujuan, et al.. (2016). Solid Pseudopapillary Tumor of the Pancreas in a 50-Year-Old Man: A Case Report and Review of the Literature. PubMed. 2(1). 23–27. 2 indexed citations
11.
Cheng, Qiong, Zheng Wang, Ruihua Ma, et al.. (2016). Lipoxin A4 protects against lipopolysaccharide-induced sepsis by promoting innate response activator B cells generation. International Immunopharmacology. 39. 229–235. 17 indexed citations
12.
Qi, Jun, et al.. (2015). [The relationship between idiopathic pulmonary fibrosis and gastroesophageal reflux disease].. PubMed. 54(8). 695–8. 3 indexed citations
13.
Liu, Fengqi, et al.. (2014). Effect of thoracic epidural blockade on hypoxia-induced pulmonary arterial hypertension in rats. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Zhang, Jianguo, et al.. (2012). [Clinicopathologic analysis of dysembryoplastic neuroepithelial tumor].. PubMed. 41(8). 534–7. 1 indexed citations
15.
Kong, Lingfei, et al.. (2010). A Novel External Esophageal Perfusion Model for Reflux-Associated Respiratory Symptoms. Pathobiology. 77(3). 163–168. 9 indexed citations
16.
Kong, Lingfei. (2009). Effect of Tongsai Granule on the Extracellular Matrix of Lung Tissue in the Acute Exacerbation of Rats with Chronic Obstructive Pulmonary Disease. Journal of traditional chinese medicine. 1 indexed citations
17.
Kong, Lingfei, et al.. (2009). The treatment of bronchial asthma in perioperative period.. 29(4). 297–299. 1 indexed citations
19.
Kong, Lingfei, et al.. (1998). A study on p16, pRb, cdk4 and cyclinD1 expression in non-small cell lung cancers. Cancer Letters. 130(1-2). 93–101. 37 indexed citations
20.
Liu, Zhengguo, et al.. (1994). An experimental study of the inhibitory effect of catechin on large intestine cancer induced by 1,2-dimethylhydrazine in mice. 16(2). 149–154. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026